Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy.

Authors :: Momparler RL
Eliopoulos N
Ayoub J
Source :: Advances in experimental medicine and biology [Adv Exp Med Biol] 2000; Vol. 465, pp. 433-46.
Publication Year :: 2000

Subjects :: Animals
Antibiotics, Antineoplastic pharmacokinetics
Azacitidine pharmacokinetics
Azacitidine pharmacology
Carcinoma, Non-Small-Cell Lung drug therapy
Decitabine
Evaluation Studies as Topic
Forecasting
Humans
Lung Neoplasms drug therapy
Antibiotics, Antineoplastic pharmacology
Azacitidine analogs & derivatives
Carcinoma, Non-Small-Cell Lung therapy
DNA Methylation drug effects
DNA Modification Methylases antagonists & inhibitors
Genetic Therapy methods
Lung Neoplasms therapy

Full Text Access

Tools